Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma

MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII and HISAHIRO MATSUBARA
Anticancer Research November 2009, 29 (11) 4433-4438;
MASAYUKI KANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m_kano{at}graduate.chiba-u.jp
SHIGERU YAMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ISAMU HOSHINO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO MURAKAMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUNORI AKUTSU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUHITO SAKATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANORI NISHIMORI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIRO USUI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIMASA MIYAZAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADASHI KAMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROHIKO TSUJII
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HISAHIRO MATSUBARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    In vitro growth suppression of human esophageal squamous cell carcinoma (TE-2, T.Tn) cells irradiated with carbon-ion beam with or without 24h CHAP31 exposure before irradiation. Curves are normalized to CHAP31 treatment alone. C-ion; Carbon-ion irradiation.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    The changes of gene expression of Rad50, Mre11A, Nbs1 and p21WAF1 after CHAP31 administration by quantitative real-time reverse transcription-PCR (qRT-PCR) analysis. Values shown are means ±standard deviation of 3 independent experiments. Control: untreated cells.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    The effect of carbon-ion 3 Gy irradiation and/or CHAP31 (5mg/kg i.v.) on in vivo tumor growth of esophageal squamous cell carcinoma (TE-2, T.Tn). Values represent the mean and standard deviation of 5 mice. Control: untreated.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    The Mre11-Rad50-Nbs1 (MRN) complex plays a crucial role in DNA double-strand break repair.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 11
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII, HISAHIRO MATSUBARA
Anticancer Research Nov 2009, 29 (11) 4433-4438;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Effects of Carbon-ion Radiotherapy combined with a Novel Histone Deacetylase Inhibitor, Cyclic Hydroxamic-acid-containing Peptide 31 in Human Esophageal Squamous Cell Carcinoma
MASAYUKI KANO, SHIGERU YAMADA, ISAMU HOSHINO, KENTARO MURAKAMI, YASUNORI AKUTSU, HARUHITO SAKATA, TAKANORI NISHIMORI, AKIHIRO USUI, YUKIMASA MIYAZAWA, TADASHI KAMADA, HIROHIKO TSUJII, HISAHIRO MATSUBARA
Anticancer Research Nov 2009, 29 (11) 4433-4438;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire